CNS PHARMACEUTICALS INC's ticker is CNSP and the CUSIP is 18978H102. A total of 23 filers reported holding CNS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $81,000 | -32.5% | 453,615 | +6.1% | 0.00% | – |
| Q2 2022 | $120,000 | -17.8% | 427,703 | 0.0% | 0.00% | – |
| Q1 2022 | $146,000 | -65.9% | 427,703 | -29.8% | 0.00% | – |
| Q4 2021 | $428,000 | -52.9% | 609,409 | 0.0% | 0.00% | – |
| Q3 2021 | $908,000 | -22.7% | 609,409 | +1.7% | 0.00% | – |
| Q2 2021 | $1,175,000 | +249.7% | 599,309 | +326.6% | 0.00% | – |
| Q1 2021 | $336,000 | +304.8% | 140,491 | +199.6% | 0.00% | – |
| Q4 2020 | $83,000 | – | 46,896 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|